Great News Involving new medications For Alzheimer’s Disease

With more than 6 million people living with Alzheimer’s disease it definitely is great news that there are some new medications on the market that are showing the possibility of slowing down the progression of the disease. These medications including Lequmbi and Donanemab are showing specific gains in clients with early-stage memory and cognitive impairment, which is why comprehensive neurological assessments like the assessments we perform are so important. If you or someone you love is noticing a change in mental status an assessment can help you to have a baseline indicating how you are performing presently, so that you can compare the results down the line after you have started treatment. Please take a look at the articles attached to this email that describe the new studies as well as early symptoms of cognitive impairment that shouldn’t go unnoticed. Let us know how we can help!!

Leave a Comment

Your email address will not be published. Required fields are marked *

Let us know that you stopped in by leaving your email address.

After you leave your email we will send you a free guide with some of the suggestions I give my clients on how to improve their overall well-being including stress reduction tips, a 16 minute excercise routine, stress reducing food choices, sleep hygeine tips, and relaxation techniques you can do yourself or share with your children.

You have Successfully Subscribed!